Methods of treating fragile X mental retardation syndrome Grant US-11491144-B2 United States of America 08 Nov 2022
1-arylalkyl-4-acylaminopiperidine compounds Grant US-10617681-B2 United States of America 14 Apr 2020
Salts and compositions useful for treating disease Grant US-10034871-B2 United States of America 31 Jul 2018
Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor… Grant US-9765027-B2 United States of America 19 Sep 2017
Kappa opioid receptor effectors and uses thereof Grant US-9540375-B2 United States of America 10 Jan 2017
Kappa opioid receptor effectors and uses thereof Grant US-9345703-B2 United States of America 24 May 2016
Kappa-receptor antagonist, such as guanidinylated naltrindole for treating metabolic… Grant US-7893080-B2 United States of America 22 Feb 2011